TheStreet

Log In

Receive full access to our market insights, commentary, newsletters, breaking news alerts, and more.
Forgot your password?Don't have an account? Sign Up Here

Join Us

Receive full access to our market insights, commentary, newsletters, breaking news alerts, and more.
Already have an account? Login here
TheStreet
JIM CRAMERINVESTINGPERSONAL FINANCERETIREMENTTECHNOLOGYMARKETSHOW-TOVIDEOFINANCIAL ADVISOR CENTER
Search

Trade with Jim Cramer 14 Days Free

Join the Action Alerts PLUS Community today!

SUBSCRIBE NOW

LATEST NEWS

Battered Pharma Stocks Bounce Back, Could Boost Retirement Portfolios
RETIREMENT

Battered pharma stocks bounce back, could boost retirement portfolios

  • By Ellen Chang
  • Nov 17, 2016 12:18 PM EST
Valeant Acquires Eyegate Licensing Rights
ETFs

Biotech ETFs May Be a Prescription for Investment Success, Especially if Trump Becomes President

  • By Brian O'Connell
  • Sep 26, 2016 3:17 PM EDT
Five ‘Industries of the Future’ Investors Can’t Ignore
VIDEO

Five ‘Industries of the Future’ Investors Can’t Ignore

  • By Gregg Greenberg
  • Feb 3, 2016 4:54 PM EST
Flexion's Latest FDA Approval Reignites Takeover Chatter
INVESTING

Two ETF plays for when biotech stocks bounce back.

  • By Gregg Greenberg
  • Feb 1, 2016 4:51 PM EST
Two ETFs to Play a Bounce Back in Biotech
VIDEO

Two ETFs to Play a Bounce Back in Biotech

  • By Gregg Greenberg
  • Feb 1, 2016 3:46 PM EST
Dating Sites: Best, Worst & Weirdest
OPINION

Times' Nat Gas Slam Affects Market

  • By Daniel Dicker
  • Jun 29, 2011 6:02 AM EDT
TheStreet
  • Terms Of Use
  • Privacy Policy
  • Advertise
  • Reprints
  • Customer Service
  • Data
  • Topic Archive
  • Subscriptions
© 2021 TheStreet, Inc. All rights reserved. Action Alerts PLUS is a registered trademark of TheStreet, Inc.